Multiparametric An Unusual Case MRI of and Penile PSMA-Targeted Prostate Cancer 18F-DCFPyL Uncovered PET/CT by

Steven P. Rowe; Michael A. Gorin; Linda C. Chu; Kenneth J. Pienta; Martin G. Pomper; Ashley E. Ross; Katarzyna J. Macura

doi:10.1097/RLU.0000000000001785

Multiparametric ^An Unusual ^Case MRI ^of and ^Penile PSMA-Targeted ^{Prostate Cancer 18}F-DCFPyL ^Uncovered PET/CT ^by

Steven P. Rowe, Michael A. Gorin, Linda C. Chu, Kenneth J. Pienta, Martin G. Pomper, Ashley E. Ross, Katarzyna J. Macura

Research output: Contribution to journal › Article › peer-review

Abstract

Multiparametric MRI (mpMRI) is currently the test of choice for imaging sites of prostate cancer located within the pelvis. However, molecular imaging with PET radiotracers that bind to prostate-specific membrane antigen is increasingly being used for this purpose and may compliment mpMRI findings. We present a case of a 59-year-old man with elevated postprostatectomy serum prostate-specific antigen level who was found on both mpMRI and prostate-specific membrane antigen–targeted PET to harbor residual prostate cancer in the corpus spongiosum along the proximal urethra.

Original language	English
Journal	Clinical Nuclear Medicine
Volume	42
Issue number	10
DOIs	https://doi.org/10.1097/RLU.0000000000001785
State	Published - 1 Oct 2017
Externally published	Yes

Keywords

DCFPyL
PSMA
prostate MRI
prostate cancer

Access to Document

10.1097/RLU.0000000000001785

Cite this

@article{eb5076150c7141d5a952d950844146df,

title = "Multiparametric An Unusual Case MRI of and Penile PSMA-Targeted Prostate Cancer 18F-DCFPyL Uncovered PET/CT by",

abstract = "Multiparametric MRI (mpMRI) is currently the test of choice for imaging sites of prostate cancer located within the pelvis. However, molecular imaging with PET radiotracers that bind to prostate-specific membrane antigen is increasingly being used for this purpose and may compliment mpMRI findings. We present a case of a 59-year-old man with elevated postprostatectomy serum prostate-specific antigen level who was found on both mpMRI and prostate-specific membrane antigen–targeted PET to harbor residual prostate cancer in the corpus spongiosum along the proximal urethra.",

keywords = "DCFPyL, PSMA, prostate MRI, prostate cancer",

author = "Rowe, {Steven P.} and Gorin, {Michael A.} and Chu, {Linda C.} and Pienta, {Kenneth J.} and Pomper, {Martin G.} and Ross, {Ashley E.} and Macura, {Katarzyna J.}",

year = "2017",

month = oct,

day = "1",

doi = "10.1097/RLU.0000000000001785",

language = "English",

volume = "42",

journal = "Clinical Nuclear Medicine",

issn = "0363-9762",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "10",

}

TY - JOUR

T1 - Multiparametric An Unusual Case MRI of and Penile PSMA-Targeted Prostate Cancer 18F-DCFPyL Uncovered PET/CT by

AU - Rowe, Steven P.

AU - Gorin, Michael A.

AU - Chu, Linda C.

AU - Pienta, Kenneth J.

AU - Pomper, Martin G.

AU - Ross, Ashley E.

AU - Macura, Katarzyna J.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Multiparametric MRI (mpMRI) is currently the test of choice for imaging sites of prostate cancer located within the pelvis. However, molecular imaging with PET radiotracers that bind to prostate-specific membrane antigen is increasingly being used for this purpose and may compliment mpMRI findings. We present a case of a 59-year-old man with elevated postprostatectomy serum prostate-specific antigen level who was found on both mpMRI and prostate-specific membrane antigen–targeted PET to harbor residual prostate cancer in the corpus spongiosum along the proximal urethra.

AB - Multiparametric MRI (mpMRI) is currently the test of choice for imaging sites of prostate cancer located within the pelvis. However, molecular imaging with PET radiotracers that bind to prostate-specific membrane antigen is increasingly being used for this purpose and may compliment mpMRI findings. We present a case of a 59-year-old man with elevated postprostatectomy serum prostate-specific antigen level who was found on both mpMRI and prostate-specific membrane antigen–targeted PET to harbor residual prostate cancer in the corpus spongiosum along the proximal urethra.

KW - DCFPyL

KW - PSMA

KW - prostate MRI

KW - prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=85043243031&partnerID=8YFLogxK

U2 - 10.1097/RLU.0000000000001785

DO - 10.1097/RLU.0000000000001785

M3 - Article

C2 - 28806262

AN - SCOPUS:85043243031

SN - 0363-9762

VL - 42

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

IS - 10

ER -